Searched for
SUVEN LIFE SHARES
Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Suven Life Sciences approves 1:2 rights issue; fixes record dateThe issue will ensure one rights equity share for every two fully-paid up equity shares held by the eligible shareholders of the company as...
- Suven Life Sciences zooms 15% as firm to consider rights issueThe company informed exchanges that the board of directors will meet on June 24, 2022, to consider raising of funds through the issue of sh...
- Suven Life Sciences rallies 11%. Here's whyShares of Suven Life have soared about 25 per cent in the last one month. In the last one year, the company has delivered over 65 per cent ...
- Suven plans to buy US-based Rising Pharmaceuticals' assetsShore Suven Pharma Inc is a joint venture between Suven Life Sciences and Shore Pharma Investments LLC of USA.
- Suven Life gets product patents from New Zealand, NorwayThese patents are valid till 2034 and 2027, respectively, the company said in a BSE filing.
- Suven gets patent from Singapore for neurological moleculeSuven Life Sciences shares were trading 0.70 per cent up at Rs 223 on BSE.
- Suven Life secures product patent in JapanSuven Life said it has been granted "one process patent from Japan corresponding to the NCEs which are for the treatment of disorders assoc...
- Suven Life secures neuro drug patent from AustraliaThe company has been granted one product patent from Australia corresponding to the (NCEs) for the treatment of disorders associated with n...
- Suven Life gets patent for neuro-degenerative moleculeWith this new patent, Suven has a total of 26 patents from New Zealand. The new patent is valid through 2033, Suven Life Sciences said in a...
- Suven Life gets patent for neuro-degenerative drugSuven Life Science grabs a patent by Australia for a drug used in the treatment of neuro-degenerative diseases.
- Suven Life gets patent for neurodegenerative drugSuven Life Sciences has been granted a patent each by Europe and Macau for drug used in the treatment of disorders associated with neurodeg...
- Suven Life shares zoom 20 per cent on getting patent for drugThe stock rose sharply by 19.12 per cent to settle at Rs 296.25 on the BSE. During the day, it jumped 19.98 per cent to Rs 298.40 -- its 52...
- Buy Suven Life at a target of Rs 95: Mitesh Thacker"Buy Suven Life with a stoploss of Rs 79 for target of Rs 95."
- Suven Life shares zoom nearly 16% post robust earningsSuven Life Sciences Ltd today skyrocketed by nearly 16 per cent after the company reported an over seven-fold increase in standalone net pr...
- Suven Life Q3 net down 16 pc at Rs 1.29 crSuven Life Sciences today posted a rise of 16.21 per cent in net profit to Rs 1.29 crore for the third quarter ended December 31, 2011.
- Heard on the Street: Suven Life Sciences climbs on Patent acquisitionsShares of Suven Life Sciences gained around 5% after the company secured four overseas product patents.
- Suven Life Sciences, US co enter deal on pre-clinical researchSuven Life Sciences has entered into an agreement with Eli Lilly to collaborate on the pre-clinical research of molecules in the therapeuti...
Load More
